Diagnostic nuclear medicine involves the use of radioactive tracers to image and/or measure the global or regional function of an organ. The radioactive tracer (radiopharmaceutical) is given to the patient by intravenous injection, orally or by other routes depending on the organ and the function to be studied.
The report forecast global Diagnostic Nuclear Medicines market to grow to reach xx Million USD in 2021 with a CAGR of xx% during the period of 2021-2026.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively."
The report demonstrates detail coverage of Diagnostic Nuclear Medicines industry and main market trends.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares of the leading Diagnostic Nuclear Medicines by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global Diagnostic Nuclear Medicines market discussed. Overall, this report covers the historical situation, present status and the future prospects of the global Diagnostic Nuclear Medicines market for 2016-2026.
Moreover,the impact of COVID-19 is also concerned. Since outbreak in December 2019, the COVID-19 virus has spread to over 100 countries and caused huge losses of lives and economy, and the global manufacturing, tourism and financial markets have been hit hard,while the online market increase. Fortunately, with the development of vaccine and other effort by global governments and orgnizations, the nagetive impact of COVID-19 is excepted to subside and the global ecnomy is excepted to recover.
Studying and analyzing the impact of Coronavirus COVID-19 on the Diagnostic Nuclear Medicines industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Tc-99m
F-18
Other
Market Segment by Product Application
Oncology
Cardiology
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS
Dongcheng
Navidea
Report Includes:
- xx data tables (appendix tables)
- Overview of global Diagnostic Nuclear Medicines market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2021 and projections of compound annual growth rates (CAGRs) through 2026
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Diagnostic Nuclear Medicines market
- Profiles of major players in the industry, including Bracco Imaging, Bayer, Curium Pharmaceuticals, Nordion, Triad Isotopes..
Research Objectives
1.To study and analyze the global Diagnostic Nuclear Medicines consumption (value & volume) by key regions/countries, product type and application, history data from 2016 to 2020, and forecast to 2026.
2.To understand the structure of Diagnostic Nuclear Medicines market by identifying its various subsegments.
3.Focuses on the key global Diagnostic Nuclear Medicines manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Diagnostic Nuclear Medicines with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Diagnostic Nuclear Medicines submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Diagnostic Nuclear Medicines Market Research Report 2021, Forecast to 2026
1 Market Study Overview
1.1 Study Objectives
1.2 Diagnostic Nuclear Medicines Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Diagnostic Nuclear Medicines Segment by Type
2.1.1 Tc-99m
2.1.2 F-18
2.1.3 Other
2.2 Market Analysis by Application
2.2.1 Oncology
2.2.2 Cardiology
2.2.3 Other
2.3 Global Diagnostic Nuclear Medicines Market Comparison by Regions (2016-2026)
2.3.1 Global Diagnostic Nuclear Medicines Market Size (2016-2026)
2.3.2 North America Diagnostic Nuclear Medicines Status and Prospect (2016-2026)
2.3.3 Europe Diagnostic Nuclear Medicines Status and Prospect (2016-2026)
2.3.4 China Diagnostic Nuclear Medicines Status and Prospect (2016-2026)
2.3.5 Japan Diagnostic Nuclear Medicines Status and Prospect (2016-2026)
2.3.6 Southeast Asia Diagnostic Nuclear Medicines Status and Prospect (2016-2026)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Diagnostic Nuclear Medicines Industry Impact
2.5.1 Diagnostic Nuclear Medicines Business Impact Assessment - Covid-19
2.5.2 Market Trends and Diagnostic Nuclear Medicines Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Diagnostic Nuclear Medicines Sales and Market Share by Manufacturer (2016-2021)
3.2 Global Diagnostic Nuclear Medicines Revenue and Market Share by Manufacturer (2016-2021)
3.3 Global Diagnostic Nuclear Medicines Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Diagnostic Nuclear Medicines Manufacturer Market Share
3.5 Top 10 Diagnostic Nuclear Medicines Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Diagnostic Nuclear Medicines Market
3.7 Key Manufacturers Diagnostic Nuclear Medicines Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Diagnostic Nuclear Medicines Industry Key Manufacturers
4.1 Bracco Imaging
4.1.1 Compan Detail
4.1.2 Bracco Imaging Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.1.3 Bracco Imaging 166 Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.1.4 Main Business Overview
4.1.5 Bracco Imaging News
4.2 Bayer
4.2.1 Compan Detail
4.2.2 Bayer Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.2.3 Bayer Diagnostic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.2.4 Main Business Overview
4.2.5 Bracco Imaging News
4.3 Curium Pharmaceuticals
4.3.1 Compan Detail
4.3.2 Curium Pharmaceuticals Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.3.3 Curium Pharmaceuticals Diagnostic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.3.4 Main Business Overview
4.3.5 Curium Pharmaceuticals News
4.4 Nordion
4.4.1 Compan Detail
4.4.2 Nordion Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.4.3 Nordion Diagnostic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.4.4 Main Business Overview
4.4.5 Nordion News
4.5 Triad Isotopes
4.5.1 Compan Detail
4.5.2 Nordion Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.5.3 Triad Isotopes Diagnostic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.5.4 Main Business Overview
4.5.5 Triad Isotopes News
4.6 Lantheus
4.6.1 Compan Detail
4.6.2 Lantheus Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.6.3 Lantheus Diagnostic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.6.4 Main Business Overview
4.6.5 Lantheus News
4.7 GE Healthcare
4.7.1 Compan Detail
4.7.2 GE Healthcare Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.7.3 GE Healthcare Diagnostic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 China Isotope & Radiation
4.8.1 Compan Detail
4.8.2 China Isotope & Radiation Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.8.3 China Isotope & Radiation Diagnostic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.8.4 Main Business Overview
4.8.5 China Isotope & Radiation News
4.9 Jubilant Pharma
4.9.1 Compan Detail
4.9.2 Jubilant Pharma Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.9.3 Jubilant Pharma Diagnostic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.9.4 Main Business Overview
4.9.5 Jubilant Pharma News
4.10 Eli Lilly
4.10.1 Compan Detail
4.10.2 Eli Lilly Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.10.3 Eli Lilly Diagnostic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.10.4 Main Business Overview
4.10.5 Eli Lilly News
4.11 Novartis
4.11.1 Compan Detail
4.11.2 Novartis Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.11.3 Novartis Diagnostic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.11.4 Main Business Overview
4.11.5 Novartis News
4.12 SIEMENS
4.12.1 Compan Detail
4.12.2 SIEMENS Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.12.3 SIEMENS Diagnostic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.12.4 Main Business Overview
4.12.5 SIEMENS News
4.13 Dongcheng
4.13.1 Company Details
4.13.2 Dongcheng Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.13.3 Dongcheng Diagnostic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.13.4 Main Business Overview
4.13.5 Dongcheng News
4.14 Navidea
4.14.1 Compan Detail
4.14.2 Navidea Diagnostic Nuclear Medicines Product Introduction, Application and Specification
4.14.3 Navidea Diagnostic Nuclear Medicines Sales, Price, Cost, Gross Margin, and Revenue (2016-2021)
4.14.4 Main Business Overview
4.14.5 Navidea News
5 Global Diagnostic Nuclear Medicines Market Segment by Big Type
5.1 Global Diagnostic Nuclear Medicines Revenue, Sales and Market Share by Big Type (2016-2021)
5.1.1 Global Diagnostic Nuclear Medicines Sales and Market Share by Big Type (2016-2021)
5.1.2 Global Diagnostic Nuclear Medicines Revenue and Market Share by Big Type (2016-2021)
5.2 Tc-99m Sales Growth Rate and Price
5.2.1 Global Tc-99m Sales Growth Rate (2016-2021)
5.2.2 Global Tc-99m Price (2016-2021)
5.3 F-18 Sales Growth Rate and Price
5.3.1 Global F-18 Sales Growth Rate (2016-2021)
5.3.2 Global F-18 Price (2016-2021)
5.4 Other Sales Growth Rate and Price
5.4.1 Global Other Sales Growth Rate (2016-2021)
5.4.2 Global Other Price (2016-2021)
6 Global Diagnostic Nuclear Medicines Market Segment by Big Application
6.1 Global Diagnostic Nuclear Medicines Sales Market Share by Big Application (2016-2021)
6.2 Oncology Sales Growth Rate (2016-2021)
6.3 Cardiology Sales Growth Rate (2016-2021)
6.4 Other Sales Growth Rate (2016-2021)
7 Global Diagnostic Nuclear Medicines Forecast
7.1 Global Diagnostic Nuclear Medicines Revenue, Sales and Growth Rate (2021-2026)
7.2 Diagnostic Nuclear Medicines Market Forecast by Regions (2021-2026)
7.2.1 North America Diagnostic Nuclear Medicines Market Forecast (2021-2026)
7.2.2 Europe Diagnostic Nuclear Medicines Market Forecast (2021-2026)
7.2.3 China Diagnostic Nuclear Medicines Market Forecast (2021-2026)
7.2.4 Japan Diagnostic Nuclear Medicines Market Forecast (2021-2026)
7.2.5 Southeast Asia Diagnostic Nuclear Medicines Market Forecast (2021-2026)
7.2.6 Other Regions Diagnostic Nuclear Medicines Market Forecast (2021-2026)
7.3 Diagnostic Nuclear Medicines Market Forecast by Type (2021-2026)
7.3.1 Global Diagnostic Nuclear Medicines Sales Forecast by Type (2021-2026)
7.3.2 Global Diagnostic Nuclear Medicines Market Share Forecast by Type (2021-2026)
7.4 Diagnostic Nuclear Medicines Market Forecast by Application (2021-2026)
7.4.1 Global Diagnostic Nuclear Medicines Sales Forecast by Application (2021-2026)
7.4.2 Global Diagnostic Nuclear Medicines Market Share Forecast by Application (2021-2026)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Diagnostic Nuclear Medicines Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Diagnostic Nuclear Medicines Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Diagnostic Nuclear Medicines
Figure Market Concentration Ratio and Market Maturity Analysis of Diagnostic Nuclear Medicines
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Diagnostic Nuclear Medicines Market Size by Big Type
Figure Global Market Share of Diagnostic Nuclear Medicines by Big Type in 2020
Figure Tc-99m Picture (2016-2021)
Figure F-18 Picture (2016-2021)
Global Diagnostic Nuclear Medicines Market Size by Big Application
Table Global Diagnostic Nuclear Medicines Market Size by Application
Figure Global Diagnostic Nuclear Medicines Market Share by Big Application in 2020
Figure Oncology Picture
Figure Cardiology Picture
Figure Other Picture
Table Global Diagnostic Nuclear Medicines Comparison by Regions (M USD) ?2016-2026?
Figure Global Diagnostic Nuclear Medicines Market Size (Million US$) (2016-2026)
Figure North America Diagnostic Nuclear Medicines Revenue (Million US$) Growth Rate (2016-2026)
Figure Europe Diagnostic Nuclear Medicines Revenue (Million US$) Growth Rate (2016-2026)
Figure China Diagnostic Nuclear Medicines Revenue (Million US$) Growth Rate (2016-2026)
Figure Japan Diagnostic Nuclear Medicines Revenue (Million US$) Growth Rate (2016-2026)
Figure Southeast Asia Diagnostic Nuclear Medicines Revenue (Million US$) Growth Rate (2016-2026)
Table Business Impact Assessment - Covid-19
Table Market Trends and Diagnostic Nuclear Medicines Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Diagnostic Nuclear Medicines Sales by Manufacturer (2016-2021)
Figure Global Diagnostic Nuclear Medicines Sales Market Share by Manufacturer in 2020
Table Global Diagnostic Nuclear Medicines Revenue by Manufacturer (2016-2021)
Figure Global Diagnostic Nuclear Medicines Revenue Market Share by Manufacturer in 2020
Table Global Diagnostic Nuclear Medicines Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Diagnostic Nuclear Medicines Manufacturer (Revenue) Market Share in 2020
Figure Top 10 Diagnostic Nuclear Medicines Manufacturer (Revenue) Market Share in 2020
Table Date of Key Manufacturers Enter into Diagnostic Nuclear Medicines Market
Table Key Manufacturers Diagnostic Nuclear Medicines Product Type
Table Mergers & Acquisitions Planning
Table Bracco Imaging Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of Bracco Imaging
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2016-2021
Table Company One Main Business
Table Company One Recent Development
Table Bayer Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of Bayer
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Bayer Recent Development
Table Curium Pharmaceuticals Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of Curium Pharmaceuticals
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Curium Pharmaceuticals Main Business
Table Curium Pharmaceuticals Recent Development
Table Nordion Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of Nordion
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Nordion Main Business
Table Nordion Recent Development
Table Nordion Main Business
Table Nordion Recent Development
Table Triad Isotopes Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of Triad Isotopes
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Triad Isotopes Main Business
Table Triad Isotopes Recent Development
Table Lantheus Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of Lantheus
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Lantheus Main Business
Table Lantheus Recent Development
Table GE Healthcare Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of GE Healthcare
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table GE Healthcare Main Business
Table GE Healthcare Recent Development
Table China Isotope & Radiation Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of China Isotope & Radiation
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table China Isotope & Radiation Main Business
Table China Isotope & Radiation Recent Development
Table Jubilant Pharma Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of Jubilant Pharma
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Jubilant Pharma Main Business
Table Jubilant Pharma Recent Development
Table Eli Lilly Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of Eli Lilly
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Eli Lilly Main Business
Table Eli Lilly Recent Development
Table Novartis Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of Novartis
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Novartis Main Business
Table Novartis Recent Development
Table SIEMENS Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of SIEMENS
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table SIEMENS Main Business
Table SIEMENS Recent Development
Table Dongcheng Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of Dongcheng
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Dongcheng Main Business
Table Dongcheng Recent Development
Table Navidea Company Profile
Table Diagnostic Nuclear Medicines Product Introduction, Application and Specification of Navidea
Table Diagnostic Nuclear Medicines Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2016-2021
Table Navidea Main Business
Table Navidea Recent Development
Figure Global Diagnostic Nuclear Medicines Sales and Growth Rate (2016-2021)
Figure Global Diagnostic Nuclear Medicines Revenue and Growth Rate (2016-2021)
Table Global Diagnostic Nuclear Medicines Sales by Regions (2016-2021)
Figure Global Diagnostic Nuclear Medicines Sales Market Share by Regions in 2020
Table Global Diagnostic Nuclear Medicines Revenue by Regions (2016-2021)
Figure Global Diagnostic Nuclear Medicines Revenue Market Share by Regions in 2020
Figure North America Diagnostic Nuclear Medicines Sales and Growth Rate (2016-2021)
Figure Europe Diagnostic Nuclear Medicines Sales and Growth Rate (2016-2021)
Figure China Diagnostic Nuclear Medicines Sales and Growth Rate (2016-2021)
Figure Japan Diagnostic Nuclear Medicines Sales and Growth Rate (2016-2021)
Figure Southeast Asia Diagnostic Nuclear Medicines Sales and Growth Rate (2016-2021)
Figure Other Regions Diagnostic Nuclear Medicines Sales and Growth Rate (2016-2021)
Table Global Diagnostic Nuclear Medicines Sales by Big Type (2016-2021)
Table Global Diagnostic Nuclear Medicines Sales Market Share by Big Type (2016-2021)
Figure Global Diagnostic Nuclear Medicines Sales Market Share by Big Type in 2019
Table Global Diagnostic Nuclear Medicines Revenue by Big Type (2016-2021)
Table Global Diagnostic Nuclear Medicines Revenue Market Share by Big Type (2016-2021)
Table Global Diagnostic Nuclear Medicines Revenue Market Share by Big Type in 2019
Figure Global Tc-99m Sales Growth Rate (2016-2021)
Figure Global Tc-99m Price (2016-2021)
Figure Global F-18 Sales Growth Rate (2016-2021)
Figure Global F-18 Price (2016-2021)
Figure Global Other Sales Growth Rate (2016-2021)
Table Global Diagnostic Nuclear Medicines Sales by Big Application (2016-2021)
Table Global Diagnostic Nuclear Medicines Sales Market Share by Big Application (2016-2021)
Figure Global Diagnostic Nuclear Medicines Sales Market Share by Big Application in 2019
Figure Global Oncology Sales Growth Rate (2016-2021)
Figure Global Cardiology Sales Growth Rate (2016-2021)
Figure Global Other Sales Growth Rate (2016-2021)
Figure Global Diagnostic Nuclear Medicines Sales and Growth Rate (2021-2026)
Figure Global Diagnostic Nuclear Medicines Revenue and Growth Rate (2021-2026)
Table Global Diagnostic Nuclear Medicines Sales Forecast by Regions (2021-2026)
Table Global Diagnostic Nuclear Medicines Market Share Forecast by Regions (2021-2026)
Figure North America Sales Diagnostic Nuclear Medicines Market Forecast (2021-2026)
Figure Europe Sales Diagnostic Nuclear Medicines Market Forecast (2021-2026)
Figure China Sales Diagnostic Nuclear Medicines Market Forecast (2021-2026)
Figure Japan Sales Diagnostic Nuclear Medicines Market Forecast (2021-2026)
Figure Southeast Asia Sales Diagnostic Nuclear Medicines Market Forecast (2021-2026)
Figure Other Regions Sales Diagnostic Nuclear Medicines Market Forecast (2021-2026)
Table Global Diagnostic Nuclear Medicines Sales Forecast by Type (2021-2026)
Table Global Diagnostic Nuclear Medicines Market Share Forecast by Type (2021-2026)
Table Global Diagnostic Nuclear Medicines Sales Forecast by Application (2021-2026)
Table Global Diagnostic Nuclear Medicines Market Share Forecast by Application (2021-2026)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Diagnostic Nuclear Medicines
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Diagnostic Nuclear Medicines Sales (K Units) Growth Rate Forecast (2020-2025)
Figure North America Diagnostic Nuclear Medicines Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Europe Diagnostic Nuclear Medicines Sales (K Units) Growth Rate Forecast (2020-2025)
Figure Europe Diagnostic Nuclear Medicines Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Japan Diagnostic Nuclear Medicines Production (K Units) Growth Rate Forecast (2020-2025)
Figure Japan Diagnostic Nuclear Medicines Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure China Diagnostic Nuclear Medicines Production (K Units) Growth Rate Forecast (2020-2025)
Figure China Diagnostic Nuclear Medicines Revenue (Million US$) Growth Rate Forecast (2020-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Bracco Imaging
Bayer
Curium Pharmaceuticals
Nordion
Triad Isotopes
Lantheus
GE Healthcare
China Isotope & Radiation
Jubilant Pharma
Eli Lilly
Novartis
SIEMENS